Skip to content

The Archive · A Source

SPRAVATO® (esketamine) nasal spray, CIII

FDA January 2025 www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf

Reports that cite this source

United States

← Back to the sources archive